Cencora, Inc. remains a significant topic within the
investment community. Their stock holdings have been adjusted by multiple firms including Kestra Private Wealth Services, Coho Partners, and Latitude Advisors who have all increased their holdings. The company's Q1 2025 earnings call unveiled
significant revenue growth and strategic actions. Sho, WCM Investment Management, and Certuity LLC have all increased their associated stock holdings as anticipation builds for Cencora's upcoming earnings report. The stock market seems
optimistic regarding the company's growth, proven by its
rising relative strength and subsequent new 52-week high following their earnings beat. Walgreens Boots Alliance has trimmed their stake in the company while Harrow announced a new patient support program with Cencora. Despite mixed Q3 results, Cencora plans to give a quarterly dividend of $0.55, indicative of their financial stability. Their Q1 2025 earnings beat revenue expectations although earnings per share lagged. Their strategic acquisition of Retina Consultants for $4.6B promises earnings-per-share growth, further cementing the company's favorable outlook. According to Jim Cramer, Cencora's CEO Steve Collis is
'Really, Really Smart' paving the way for further confidence in the company's upward trajectory.
Cencora COR News Analytics from Thu, 01 Aug 2024 07:00:00 GMT to Sat, 15 Feb 2025 20:34:20 GMT -
Rating 9
- Innovation 8
- Information 7
- Rumor 3
